The production and R&D structure of the Brazilian pharmaceutical industry: The role of public procurement and public drug production

References

• Abernathy , W.J. 1978 . The productivity dilemma: roadblock to innovation in the automobile industry , Baltimore : The Johns Hopkins University Press .
   Google Scholar
• Abiquif , 2010 . Mercado: estatísticas . Available from: http://www.abiquif.org.br/mercado_estatisticas.html [Accessed 3 February 2010] .
   Google Scholar
• Agência Câmara , 2009 . Sem recursos, laboratórios oficiais têm 66% de ociosidade . Available from: http://www.camara.gov.br/internet/agencia/imprimir.asp?pk=134511 [Accessed 10 May 2010] .
   Google Scholar
• Agência Fapesp , 2009 . Genéricos públicos . Available from: http://www.agencia.fapesp.br/materia/10712/noticias/genericos-publicos.htm [Accessed 11 May 2010] .
   Google Scholar
• Capanema , L.X.L. 2006 . A indústria farmacêutica brasileira e a atuacão do BNDES . BNDES Setorial , 23 : 193 – 216 .
   Google Scholar
• Capanema , L.X.L. , Palmeira Filho , P.L. and Pieroni , J.P. 2008 . Apoio do BNDES ao complexto industrial da saúde: a experiência do Profarma e seus desdobramentos . BNDES Setorial , 27 : 3 – 20 .
   Google Scholar
• Cassier , M. and Correa , M. 2007 . Intellectual property and public health: copying of HIV/Aids drugs by Brazilian public and private pharmaceutical laboratories . Electronic Journal of Communication, Information & Innovation in Health , 1 ( 1 ) : 83 – 90 .
   Google Scholar
• Congressional Budget Office (CBO) , 2006 . Research and development in the pharmaceutical industry. The Congress of the United States . Available from: http://www.cbo.gov/ftpdocs/76xx/doc7615/10-02-DrugR-D.pdf [Accessed 20 September 2010] .
   Google Scholar
• Chadha , A. 2009 . Product cycles, innovation, and exports: a study of Indian pharmaceuticals . World Development , 37 ( 9 ) : 1478 – 1483 . doi: 10.1016/j.worlddev.2009.01.002
   Web of Science ®Google Scholar
• Chagnon , R.P. , 2007 . Os Caminhos da estratégia na Fiocruz: uma avaliação do sistema de planejamento e suas interfaces com uma unidade de produção de insumos estratégicos em saúde Farmanguinhos . Dissertation (MA), Sergio Arouca National School of Public Health .
   Google Scholar
• Chaudhuri , S. 2010 . R&D for development of new drugs for neglected diseases in India . International Journal of Technology and globalization , 5 ( 1/2 ) : 61 – 75 . doi: 10.1504/IJTG.2010.033666
   Google Scholar
• Cytrynowicz , M.M. 2007 . Origens e trajetória da indústria farmacêutica no Brasil [Origins and trajectory of the pharmaceutical industry in Brazil] , São Paulo : Narrativa-um .
   Google Scholar
• Febrafarma , 2007 . Estudos Febrafarma n. 13: Avaliação da política industrial, tecnológica e de comércio exterior para o setor farmacêutico [Febrafarma study series number 13: Evaluation of the industrial, technological and foreign trade policy for the pharmaceutical industry] . São Paulo : Febrafarma .
   Google Scholar
• Flynn , M. 2008 . Public production of anti-retroviral medicines in Brazil 1990–2007 . Development and Change , 39 ( 4 ) : 513 – 536 . doi: 10.1111/j.1467-7660.2008.00494.x
   Web of Science ®Google Scholar
• Fujimoto , T. 1999 . The evolution of a manufacturing system at Toyota , New York : Oxford University Press .
   Google Scholar
• Gadelha , C.A.G. , Barbosa , P.R. , Maldonado , J. , Vargas , M. , and Costa , L. , 2010 . O complexo econômico-industrial da saúde: conceitos e características gerais [The health economic-industrial complex: concepts and general features] . Informe CEIS , 1 1 , 1 – 17 .
   Google Scholar
• Galvão , J. 2002 . Access to antiretroviral drugs in Brazil . The Lancet , 360 ( 9348 ) : 1862 – 1865 . doi: 10.1016/S0140-6736(02)11775-2
   PubMed Web of Science ®Google Scholar
• Gouvea , R. and Kassicieh , S. 2005 . Using resources in R&D policy planning: Brazil, the Amazon and biotechnology . Technological Forecasting & Social Change , 72 : 535 – 547 . doi: 10.1016/j.techfore.2004.06.003
   Web of Science ®Google Scholar
• Hubbard , T. and Love , J. 2004 . A new trade framework for global healthcare R&D . Plosbiology , 2 ( 2 ) : 147 – 150 .
   Google Scholar
• Jornal do Brasil , 2011 . Brasil vai produzir quatro novos medicamentos . Available from: http://www.jb.com.br/ciencia-e-tecnologia/noticias/2011/04/06/brasil-vai-produzir-quatro-novos-medicamentos/ [Accessed 11 January 2012] .
   Google Scholar
• JRC , 2010 . R&D ranking of the top 1000 non-EU companies by industrial sector . Joint Research Center, Directorate General Research, European Commission. Available from: http://iri.jrc.ec.europa.eu/research/scoreboard_2010.htm [Accessed 18 November 2010] .
   Google Scholar
• Lago , R.F. and Costa , N.R. 2009 . Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian national STD/AIDS program . Caderno de Saúde Pública , 25 ( 10 ) : 2273 – 2284 . doi: 10.1590/S0102-311X2009001000017
   Web of Science ®Google Scholar
• Landriault , E. and Matlin , S.A. , 2009 . Monitoring financial flows for health research 2009: behind the global numbers . Geneva : Global Forum for Health Research .
   Google Scholar
• Mani , S. , 2009 . Has India become more innovative since 1991? Analysis of the evidence and some disquieting features . Working Paper No 415, Centre for Development Studies , India .
   Google Scholar
• Medici , A.C. , 2010 . Medicamentos excepcionais e prioridades de saúde no Brasil . Available from: http://monitordesaude.blogspot.com/2010/09/medicamentos-excepcionais-e-prioridades.html [Accessed 16 September 2010] .
   Google Scholar
• Ministério da Saúde , 2009 . Parcerias público-privadas viabilizam produção nacional de 24 fármacos . Assessoria de Imprensa. Available from: http://portal.saude.gov.br/portal/aplicacoes/reportagensEspeciais/default.cfm?pg=dspDetalhes&id_area=124&CO_NOTICIA=10058 [Accessed 23 September 2010] .
   Google Scholar
• Morel , C.M. 2003 . Neglected diseases: under-funded research and inadequate health interventions: can we change this reality? . EMBO Reports , 4 : S35 – S38 . doi: 10.1038/sj.embor.embor851
   PubMed Web of Science ®Google Scholar
• Moysés Júnior , Z. , 2010 . Health innovation and access to essential medicines . In : Presentation at IBSA Academic Forum , 13–14 April , Brasília .
   Google Scholar
• Nóbrega , O.T. , Marques , A.R. , Araújo , A.C.G. , Karnikowski , M.G.O. , Naves , J.O.S. and Silver , L.D. 2007 . Retail prices of essential drugs in Brazil: an international comparison . Pan American Journal of Public Health , 22 ( 2 ) : 118 – 123 . doi: 10.1590/S1020-49892007000700006
   Web of Science ®Google Scholar
• Nunn , A.S. , Fonseca , E.M. , Bastos , F.I. , Gruskin , S. and Salomon , J.A. 2007 . Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment . PLoS Medicine , 4 ( 11 ) : 1804 – 1817 . doi: 10.1371/journal.pmed.0040305
   Web of Science ®Google Scholar
• Orsi , F. , Camara , M. and Coriat , B. 2006 . “ AIDS, TRIPS and ‘TRIPS plus’: the case for developing and less developed countries ” . In Intellectual property rights: innovation, governance and the institutional environment , Edited by: Andersen , B. 70 – 106 . Northampton , MA : Edward Elgar .
   Google Scholar
• Palmeira Filho , P.L. and Capanema , L.X.L. 2010 . “ A indústria farmacêutica nacional: desafios rumo à inserção global ” . In O BNDES em um Brasil em transição , Edited by: Alémand , A.C. and Giambiagi , F. 307 – 318 . Rio de Janeiro : BNDES .
   Google Scholar
• Pró-Genéricos , 2010 . Informações de mercado [online]. Brazilian Generic Medications Industry Association. Available from: http://www.progenericos.org.br/infomercado2009.shtml [Accessed 30 May 2010] .
   Google Scholar
• Revista Acesso , 2009 . Falta de recursos limita produção de laboratórios públicos . Available from: http://www.protec.org.br/noticias_inovacao_tecnologica_farmacos_medicamentos_produtos_farmaceuticos.asp?cod=120 [Accessed 07 May 2010] .
   Google Scholar
• Rodrigues , W.C.V. and Soler , O. 2009 . Licença compulsória do efavirenz no Brasil em 2007: contextualização . Pan American Journal of Public Health , 6 ( 6 ) : 553 – 559 .
   Google Scholar
• Rossi , F. 2008 . Technical, economic and legal evaluation of antiretroviral production capacity in Brazil , Brasilia : International Poverty Centre .
   Google Scholar
• Sako , M. 1992 . Prices, quality and trust: inter-firm relations in Britain & Japan , Cambridge : Cambridge University Press .
   Google Scholar
• Sorte Junior , W.F. 2008 . New trends in inter-firm relations in the Brazilian automobile industry . Forum of International Development Studies , 37 : 187 – 209 .
   Google Scholar
• The Economic Times , 2010 . Ranbaxy transfers R&D unit to Daiichi Sankyo . Available from: http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/Ranbaxy-transfers-RD-unit-to-Daiichi-Sankyo/articleshow/6121932.cms [Accessed 15 August 2010] .
   Google Scholar
• The Financial Express , 2009 . Sanofi acquires Shantha Biotechnics . Available from: http://www.financialexpress.com/news/sanofi-acquires-shantha-biotechnics/494822/ [Accessed 15 August 2010] .
   Google Scholar
• Timmons , H. , 2010 . Abbott buys drug maker in India for $3.7 Billion . Available from: http://www.nytimes.com/2010/05/22/business/global/22drug.html?_r=1&ref=business [Accessed 15 August 2010] .
   Google Scholar
• Vidotti , C.C.F. , Castro , L.L.C. and Calil , S.S. 2008 . New drugs in Brazil: do they meet Brazilian public health needs? . Pan American Journal of Public Health , 24 ( 1 ) : 36 – 45 . doi: 10.1590/S1020-49892008000700005
   Web of Science ®Google Scholar
• Womack , J.P. , Jones , D.T. and Roos , D. 1991 . The machine that changed the world: the story of Lean Production System , New York : HarperPerennial .
   Google Scholar